Keyphrases
Glucose Transporter 4 (GLUT4)
100%
Altered Glucose Metabolism
100%
Obesity-related Diseases
100%
Lipid Metabolism
100%
Cardiovascular Disease
100%
Acrp30
50%
White Adipose Tissue
33%
Visceral Obesity
33%
Obesity
25%
Insulin
25%
Molecular Mechanism
16%
Adipocyte
16%
Glucose Flux
16%
Disease Progression
16%
Insulin Resistance
16%
Visceral Adipose Tissue
16%
Mouse Model
16%
Lipid Profile
8%
High-fat Diet
8%
Plasma Lipoproteins
8%
Metabolic Abnormalities
8%
Carbohydrate Metabolism
8%
Diet-induced
8%
Adipose Cells
8%
C57BL
8%
Insulin Sensitivity
8%
Measurable Change
8%
Male Mice
8%
Secretory Proteins
8%
Pathophysiological Changes
8%
Insulinemic Response
8%
Lipoprotein Lipids
8%
Overexpressing
8%
Type 2 Diabetes Risk
8%
Metabolic Disturbances
8%
GLUT4 Expression
8%
Oral Glucose Tolerance Test
8%
Obese Patients
8%
Metabolic Parameters
8%
Systematic Description
8%
Liver
8%
Novel Therapeutic Targets
8%
Obese Men
8%
Glycemic Response
8%
Metabolic Changes
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Insulin Sensitizers
8%
Normal Weight
8%
Diabetes Disease
8%
Thiazolidinediones
8%
Medicine and Dentistry
Cardiovascular Disease
100%
Lipid Metabolism
100%
Glucose Transporter 4
100%
Glucose Metabolism
100%
Adiponectin
46%
White Adipose Tissue
30%
Maturity Onset Diabetes of the Young
15%
Disease Exacerbation
15%
Insulin Resistance
15%
Adipose Tissue
15%
Adipocyte
15%
Body Weight
7%
Thiazolidinedione
7%
Water-Electrolyte Imbalance
7%
Carbohydrate Metabolism
7%
Hope
7%
Insulin Sensitizing Agent
7%
Insulin Sensitivity
7%
Secretory Protein
7%
Glycemic
7%
Downregulation
7%
Lipoprotein
7%
High Fat Food
7%
Diseases
7%
Oral
7%
Biochemistry, Genetics and Molecular Biology
Lipid Metabolism
100%
Glucose Metabolism
100%
GLUT4
100%
Adiponectin
46%
Mouse Model
15%
Adipocyte
15%
Insulin Resistance
15%
C57BL 6 Mouse
7%
Lipoprotein Blood Level
7%
Thiazolidinedione
7%
Hope
7%
Downregulation
7%
Body Weight
7%
Secretory Protein
7%
Carbohydrate Metabolism
7%
Insulin Sensitivity
7%
Sensitization
7%
Lipid Profile
7%
Metabolic Disorder
7%